Yap, W.-K.; Shih, M.-C.; Chang, Y.-C.; Lin, C.-H.; Huang, S.-M.; Tsai, T.-Y.; Chang, C.-F.; Hsu, C.-C.; Tseng, C.-K.; Chen, M.-F.;
et al. Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era. Biomedicines 2022, 10, 2989.
https://doi.org/10.3390/biomedicines10112989
AMA Style
Yap W-K, Shih M-C, Chang Y-C, Lin C-H, Huang S-M, Tsai T-Y, Chang C-F, Hsu C-C, Tseng C-K, Chen M-F,
et al. Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era. Biomedicines. 2022; 10(11):2989.
https://doi.org/10.3390/biomedicines10112989
Chicago/Turabian Style
Yap, Wing-Keen, Ming-Chieh Shih, Yu-Chen Chang, Chia-Hsin Lin, Shih-Ming Huang, Tsung-You Tsai, Ching-Fu Chang, Chih-Chung Hsu, Chen-Kan Tseng, Miao-Fen Chen,
and et al. 2022. "Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era" Biomedicines 10, no. 11: 2989.
https://doi.org/10.3390/biomedicines10112989
APA Style
Yap, W.-K., Shih, M.-C., Chang, Y.-C., Lin, C.-H., Huang, S.-M., Tsai, T.-Y., Chang, C.-F., Hsu, C.-C., Tseng, C.-K., Chen, M.-F., Tsan, D.-L., Liau, C.-T., Hou, M.-M., Chao, Y.-K., Chiu, C.-H., & Hung, T.-M.
(2022). Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era. Biomedicines, 10(11), 2989.
https://doi.org/10.3390/biomedicines10112989
